መነሻ › ትሪፕል-ኔጌቲቭ የደረት ካንሰር › North Carolina › Durham
በDurham፣ NC ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ 12 ጥናቶች በDurham እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke University, Durham
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 ማይል ርቀት
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Duke Cancer Institute, Durham
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke University, Durham
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Duke Cancer Institute, Durham
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke University Medical Center, Durham
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of North Carolina, Chapel Hill · 10 ማይል ርቀት
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Duke Cancer Institute /ID# 276267, Durham
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of North Carolina, Chapel Hill · 10 ማይል ርቀት
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
A Study of NX-1607 in Adults With Advanced Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of North Carolina, Chapel Hill · 10 ማይል ርቀት
በሌሎች ከተሞች ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ ጥናቶች
- Houston, TX42 ጥናቶች
- New York City, NY31 ጥናቶች
- Nashville, TN28 ጥናቶች
- Los Angeles, CA27 ጥናቶች
- Boston, MA26 ጥናቶች
- San Antonio, TX23 ጥናቶች
- St. Louis, MO21 ጥናቶች
- Arlington, VA20 ጥናቶች
- Atlanta, GA20 ጥናቶች
- Dallas, TX18 ጥናቶች
- Chicago, IL16 ጥናቶች
- Columbus, OH16 ጥናቶች
በDurham ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር64 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)58 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር39 ጥናቶች
- Multiple Myeloma37 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ33 ጥናቶች
- Metastatic Cancer33 ጥናቶች
- የፕሮስቴት ካንሰር32 ጥናቶች
- የሳንባ ካንሰር32 ጥናቶች
- የኮሎሬክታል ካንሰር28 ጥናቶች
- የእንቁላል ካንሰር27 ጥናቶች
- ክሮኒክ ሊምፎሳይቲክ ሉኬሚያ27 ጥናቶች
- የልብ ድካም26 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።